Health Care / Medicine

Healthcare Groups Praise Unanimous Committee Approval Of MA Prior Auth Bill

The House Ways and Means Committee unanimously advanced a bill to reform Medicare Advantage prior authorization requirements.

Coalition Urges Policymakers To Reject No Surprises Act Enforcement Bill

The Coalition Against Surprise Medical Billing launched a campaign opposing the No Surprises Act Enforcement Act, arguing it would worsen IDR process abuse.

Nearly 200 Organizations Back Bill To Expand Access To Clinical Trials

Nearly 200 healthcare and patient advocacy organizations endorsed the bipartisan Clinical Trial Modernization Act, which seeks to reduce financial barriers and expand access to clinical trials for underrepresented patients.

Former Mayo Clinic Leader Sues System Over Alleged AI Cover-Up: 6 Things To Know

A former Mayo Clinic research director claims she was silenced, demoted, and ultimately fired for sounding the alarm on AI safety and patient privacy lapses at the health system. Traci Tamiko Eto is now suing Mayo for retaliation.

Elevance Sues CMS Over Star Ratings, Seeks Same Recalculation Applied To Clover

Elevance alleges that CMS unlawfully refused to recalculate its 2026 Medicare Advantage Star Ratings on the same basis that it recently recalculated Clover Health's ratings after a court ruling.

Report Highlights Private Equity’s Lesser-Known Strategy: Nonprofit Joint Ventures

A new report finds private equity firms are increasingly using joint ventures with nonprofit health systems to expand in healthcare, prompting calls for greater oversight.

Debunked: A Little More Transparency, A Little More Action

Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed some of the takeaways from UnitedHealth Group’s press event, transparency, and pharma company Lilly’s efforts to hold hospitals accountable in the 340B drug discount program

Medicine’s Monopoly Problem

A 'cynical optimist' breaks down how law impacts the healthcare you receive.

New Bill Led By Democrats Aims To Cap Medicare Out-Of-Pocket Costs

The Medicare Cost Cap Act seeks to create a $5,000 cap on out-of-pocket costs for traditional Medicare beneficiaries.

The Things To Think About Before Taking Your Biotech Company Public

The biotech IPOs window is now open, but that doesn’t mean every company can go through it.

Is It Likely That The WISeR Model Will Be Repealed?

Congressional Democrats are seeking to repeal the controversial WISeR model, but experts are unsure if their efforts will succeed.

KFF: Insurer Participation In ACA Marketplaces Is Down

KFF’s analysis found that the average number of issuers offering plans on the Marketplaces declined to 9 issuers per state in 2026, compared to 9.6 issuers per state in 2025.

FDA Reversal On uniQure Gene Therapy Is Another Sign Of Renewed Regulatory Flexibility

This gene therapy is the latest in a growing list of rare disease treatments to receive reconsideration from an FDA that appears to be swinging back to regulatory flexibility.

Amgen Turns To An Independent Review To Defend Rare Disease Drug In FDA Crosshairs

FDA concerns about Amgen’s Tavneos were sparked by securities fraud litigation against ChemoCentryx, the company that originally developed the rare disease drug. The FDA wants to withdraw Tavneos’s approval, citing safety risks and alleged manipulation of the drug’s clinical trial data.

What The ‘One Nation, Overcharged’ Campaign Aims To Achieve

One Nation, Overcharged, a campaign backed by the Robert Wood Johnson Foundation, launched to raise awareness of rising healthcare costs.